-transparent.png){kind=logo}
Polychemotherapy for soft tissue sarcomas has been reported to produce response rates ranging from 24--60% (1, 2). Immunotherapy has reportedly prolonged survival after surgery for some tumors and enhanced the effectiveness of chemotherapy (3, 4). This report summarizes our preliminary experience with the combination of cyclophosphamide, adriamycin, imidazole carboxamide (DTIC), and actinomycin D (CAIA) with or without methanol extraction residue of BCG (MER) in patients with advanced sarcomas.
Related Publications
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1975,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1974,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1974,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1975,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1974,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1977,
Oncology,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1976,
Cancer treatment reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
June 1972,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1975,
Cancer chemotherapy reports,
E T Creagan, and
J H Edmonson, and
R G Hahn, and
D L Ahmann, and
H F Bisel, and
R T Eagan
January 1974,
Cancer chemotherapy reports,
